We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Distribution Alliance for Infectious Disease Tests

By Labmedica staff writers
Posted on 03 Aug 2004
An agreement has been announced that grants DakoCytomation (Glostrup, Denmark) co-exclusive rights to market and sell the infectious disease diagnostic tests based on the nucleic acid detection of LightUp Technologies AB (Huddinge, Sweden).

The parties will work jointly to achieve a strong market penetration and to develop more products based on LightUp's ReSSQ assay technology and DakoCytomation's knowledge of markets and customer contacts. More...
LightUp is a company developing and commercializing innovative technologies for the fast-growing molecular diagnostic segment of the in vitro diagnostics industry. The company's ReSSQ assays provide simpler and more accurate identification and quantification of disease-generating organisms. The LightUp Probe at the heart of the method is designed to work with real-time polymerase chain reaction (PCR) and can be used in many medical applications.

DakoCytomation is a leading cancer diagnostics company in the field of personalized medicine. The company provides systems solutions for clinical laboratories and life science research. Its tests and instruments allow doctors to link diagnostic results to specific therapies and optimize patient care.



Related Links:
LightUp Technologies
DakoCytomation

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.